Press Release

Faron Pharmaceuticals Oy in £10m placing

Panmure Gordon raises £10 million for Faron Pharmaceuticals Oy

Panmure Gordon & Co, a leading independent institutional stockbroker and investment bank, is pleased to advise that it has acted as Financial adviser, Nominated Adviser and Corporate Broker on behalf of Allergy Therapeutics plc (AGY.L) in raising £11.5m.

 

Panmure Gordon & Co, a leading independent institutional stockbroker and investment bank, is pleased to advise that it has acted as placing agent and broker in the placing of 4,300,000 new ordinary shares in Fusionex International plc (“Fusionex”, “the Company” or “the Group”) raising gross proceeds of £13.975m.

The placing price was 325p per Ordinary Share and was placed at a tight discount of 1.5% to the market close.

Panmure Gordon, a leading independent institutional stockbroker and investment bank is pleased to advise that it has acted on behalf of GLI Finance Limited, a specialist provider of finance to small and medium sized enterprises both direct and through a variety of finance platforms, in placing 34.5 million new ordinary shares at 58 pence per share with new and existing investors, raising £20.0 million. Completion of the placing is subject to shareholder approval.

Interview

The Times profiles CEO Ian Axe

Panmure Gordon’s CEO Ian Axe was interviewed in The Times, and spoke about his career and vision for the company.

FILTER BY:
RESET
Top